SG11201809007YA - Substituted fused pyrimidinone compounds - Google Patents
Substituted fused pyrimidinone compoundsInfo
- Publication number
- SG11201809007YA SG11201809007YA SG11201809007YA SG11201809007YA SG11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA SG 11201809007Y A SG11201809007Y A SG 11201809007YA
- Authority
- SG
- Singapore
- Prior art keywords
- torrent
- bhat
- dist
- tal
- gujarat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1111111111111111111111111111111111111111111111111111111111111111111111111 Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2017/187324 Al 02 November 2017 (02.11.2017) WIP0 I PCT (51) International Patent Classification: (74) Agent: MAJUMDAR, Subhatosh et al.; S. Majumdar C07D 405/14 (2006.01) A61K 31/517 (2006.01) & Co., 5 Harish Mukherjee Road, State of West Bengal, CO7D 403/14 (2006.01) A61P 11/00 (2006.01) Kolkata 700 025 (IN). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/IB2017/052352 kind of national protection available): AE, AG, AL, AM, (22) International Filing Date: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, 25 April 2017 (25.04.2017) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (25) Filing Language: English HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, (26) Publication Language: English KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (30) Priority Data: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 201621014526 26 April 2016 (26.04.2016) IN SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: TORRENT PHARMACEUTICALS LIMITED [IN/IN]; Torrent House, Off Ashram Road, Gu- (84) Designated States (unless otherwise indicated, for every jarat, Ahmedabad 380 009 (IN). kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (72) Inventors: DUTT, Chaitanya; Torrent Research Centre, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, Tal & Dist. Gandhinagar, Gujarat, Bhat 382 428 (IN). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, JOSHI, Deep a; ; Torrent Research Centre, Tal & Dist. Gand-EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, hinagar, Gujarat, Bhat 382 428 (IN). RODE, Milind; Tor- MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, rent Research Centre, Tal & Dist. Gandhinagar, Gujarat, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Bhat 382 428 (IN). SRIVASTAVA, Sanjay; Torrent Re-KM, ML, MR, NE, SN, TD, TG). search Centre, Tal & Dist. Gandhinagar, Gujarat, Bhat 382 = 428 (IN). TULI, Davinder; Torrent Research Centre, Tal Declarations under Rule 4.17: _ — & Dist. Gandhinagar, Gujarat, Bhat 382 428 (IN). GUP- — as to applicant's entitlement to apply for and be granted a TA, Ramesh, Chandra; Torrent Research Centre, Tal & patent (Rule 4.17(ii)) Dist. Gandhinagar, Gujarat, Bhat 382 428 (IN). RAI, Deep- — as to the applicant's entitlement to claim the priority of the ak; Torrent Research Centre, Tal & Dist. Gandhinagar, Gu earlier application (Rule 4.17(iii)) jarat, Bhat 382 428 (IN). JAMADARKHANA, Prashant; = = - Torrent Research Centre, Tal & Dist. Gandhinagar, Gujarat, Published: Bhat 382 428 (IN). DESHPANDE, Shailesh; Torrent Re- — with international search report (Art. 21(3)) = search Centre, Tal & Dist. Gandhinagar, Gujarat, Bhat 382 428 (IN). MISHRA, Vivek; Torrent Research Centre, Tal = & Dist. Gandhinagar, Gujarat, Bhat 382 428 (IN). ABRA- = HAM, Jaya; Torrent Research Centre, Tal & Dist. Gandhi- nagar, Gujarat, Bhat 382 428 (IN). = = = = (54) Title: SUBSTITUTED FUSED PYRIMIDINONE COMPOUNDS (57) : Provided herein are novel fused pyrimidinone derivatives of For- = ER 2],i mula (I) and synthetic intermediates that are useful in preparing the compounds of formula (I). Further provided herein is a method for preparation of a compound of formula (I) or intermediates, a pharmaceutical composition comprising a compound — Il .4 ei (R ']q ,X of formula (I), and use of a compound of formula (I) . 41:11 R 8 M _N IN R 5 GC \ Il R 6 IN Il R 3 Z lip [R 4 ] q 0 N (I) O
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201621014526 | 2016-04-26 | ||
PCT/IB2017/052352 WO2017187324A1 (en) | 2016-04-26 | 2017-04-25 | Substituted fused pyrimidinone compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201809007YA true SG11201809007YA (en) | 2018-11-29 |
Family
ID=58745288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201809007YA SG11201809007YA (en) | 2016-04-26 | 2017-04-25 | Substituted fused pyrimidinone compounds |
Country Status (16)
Country | Link |
---|---|
US (1) | US20190127381A1 (en) |
EP (1) | EP3448855A1 (en) |
JP (1) | JP2019514906A (en) |
KR (1) | KR20180135486A (en) |
CN (1) | CN109071515A (en) |
AR (1) | AR108327A1 (en) |
AU (1) | AU2017256175A1 (en) |
BR (1) | BR112018072063A2 (en) |
CA (1) | CA3021542A1 (en) |
EA (1) | EA201892370A1 (en) |
IL (1) | IL262363A (en) |
MX (1) | MX2018012966A (en) |
PH (1) | PH12018502246A1 (en) |
SG (1) | SG11201809007YA (en) |
TW (1) | TW201806953A (en) |
WO (1) | WO2017187324A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10751339B2 (en) | 2018-01-20 | 2020-08-25 | Sunshine Lake Pharma Co., Ltd. | Substituted aminopyrimidine compounds and methods of use |
CN111269231B (en) * | 2018-12-04 | 2023-06-09 | 安徽中科拓苒药物科学研究有限公司 | Selective PI3K delta inhibitor and application thereof |
CN116987085A (en) * | 2022-04-26 | 2023-11-03 | 安徽中科拓苒药物科学研究有限公司 | PI3K delta inhibitor and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2760012B1 (en) | 1997-02-26 | 2000-08-18 | Oreal | COMPOSITIONS FOR DYEING KERATINIC FIBERS CONTAINING PARA-AMINOPHENOLS, DYEING METHOD, NOVEL PARA-AMINOPHENOLS AND PREPARING METHOD THEREOF |
MXPA03008560A (en) * | 2001-03-22 | 2004-06-30 | Abbot Gmbh & Co Kg | Single-stage pfc + ballast control circuit/general purpose power converter. |
NZ587051A (en) | 2008-01-04 | 2012-12-21 | Intellikine Llc | Isoquinolinone derivatives, compositions and methods of inhibiting phosphatidyl inositol-3 kinase (pi3 kinase) |
WO2012037204A1 (en) | 2010-09-14 | 2012-03-22 | Exelixis, Inc. | Inhibitors of pi3k-delta and methods of their use and manufacture |
EP2619209A1 (en) * | 2010-09-24 | 2013-07-31 | Gilead Calistoga LLC | Atropisomers of pi3k-inhibiting compounds |
UY33337A (en) * | 2010-10-18 | 2011-10-31 | Respivert Ltd | SUBSTITUTED DERIVATIVES OF 1H-PIRAZOL [3,4-d] PYRIMIDINE AS INHIBITORS OF PHOSFOINOSITIDE 3-KINASES |
-
2017
- 2017-04-19 TW TW106113084A patent/TW201806953A/en unknown
- 2017-04-25 JP JP2018555987A patent/JP2019514906A/en active Pending
- 2017-04-25 BR BR112018072063A patent/BR112018072063A2/en not_active Application Discontinuation
- 2017-04-25 CN CN201780025852.8A patent/CN109071515A/en active Pending
- 2017-04-25 EA EA201892370A patent/EA201892370A1/en unknown
- 2017-04-25 SG SG11201809007YA patent/SG11201809007YA/en unknown
- 2017-04-25 EP EP17724911.7A patent/EP3448855A1/en not_active Withdrawn
- 2017-04-25 AU AU2017256175A patent/AU2017256175A1/en not_active Abandoned
- 2017-04-25 MX MX2018012966A patent/MX2018012966A/en unknown
- 2017-04-25 US US16/095,597 patent/US20190127381A1/en not_active Abandoned
- 2017-04-25 WO PCT/IB2017/052352 patent/WO2017187324A1/en active Application Filing
- 2017-04-25 KR KR1020187033910A patent/KR20180135486A/en unknown
- 2017-04-25 CA CA3021542A patent/CA3021542A1/en not_active Abandoned
- 2017-04-26 AR ARP170101057A patent/AR108327A1/en unknown
-
2018
- 2018-10-14 IL IL262363A patent/IL262363A/en unknown
- 2018-10-22 PH PH12018502246A patent/PH12018502246A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN109071515A (en) | 2018-12-21 |
EA201892370A1 (en) | 2019-03-29 |
WO2017187324A1 (en) | 2017-11-02 |
US20190127381A1 (en) | 2019-05-02 |
BR112018072063A2 (en) | 2019-02-12 |
TW201806953A (en) | 2018-03-01 |
MX2018012966A (en) | 2019-01-17 |
PH12018502246A1 (en) | 2019-08-19 |
EP3448855A1 (en) | 2019-03-06 |
IL262363A (en) | 2018-11-29 |
CA3021542A1 (en) | 2017-11-02 |
AU2017256175A1 (en) | 2018-11-15 |
KR20180135486A (en) | 2018-12-20 |
JP2019514906A (en) | 2019-06-06 |
AR108327A1 (en) | 2018-08-08 |
WO2017187324A9 (en) | 2018-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
SG11201805838UA (en) | Macrocyclic mcl1 inhibitors for treating cancer | |
SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
SG11201811414TA (en) | Heterocyclic compounds as immunomodulators | |
SG11201804170RA (en) | Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders | |
SG11201408821SA (en) | Selective pi3k delta inhibitors | |
SG11201907544VA (en) | Jak inhibitors containing a 4-membered heterocyclic amide | |
SG11201803627XA (en) | N-substituted indole derivatives as pge2 receptor modulators | |
SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
SG11201408094YA (en) | Neprilysin inhibitors | |
SG11201408237YA (en) | Compound as wnt signaling inhibitor, composition, and use thereof | |
SG11201811161YA (en) | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme | |
SG11201408750VA (en) | NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS | |
SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
SG11201909376TA (en) | Crystalline forms of a jak inhibitor compound | |
SG11201407546QA (en) | Novel ring-substituted n-pyridinyl amides as kinase inhibitors | |
SG11201407326XA (en) | Compositions and methods for treatment of mucositis | |
SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
SG11201407184PA (en) | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals | |
SG11201804774YA (en) | Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031 | |
SG11201804589TA (en) | Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists | |
SG11201908097YA (en) | Pyrimidine derivatives as pge2 receptor modulators | |
SG11201810389XA (en) | New antibacterial compounds | |
SG11201903091VA (en) | Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors |